| Package | dk.kip.rkkp.fhir.ig.core |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | https://kip.rkkp.dk/fhir/https://build.fhir.org/ig/KIP-infrastructure/implementation-guide/ValueSet-Immunoterapi.html |
| Url | https://kip.rkkp.dk/fhir/ValueSet/Immunoterapi |
| Version | 2.11.0 |
| Status | active |
| Date | 2022-07-18T00:00:00+02:00 |
| Name | Immunoterapi |
| Title | Immunoterapi |
| Experimental | True |
| Description | Immunoterapi |
No resources found
| CodeSystem | |
ATC  | WHO ATC |
| GenericValues | Generic values |
| TreatmentUnspecified | Treatment unspecified |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet Immunoterapi
This value set includes codes based on the following rules:
FHIRhttps://kip.rkkp.dk/fhir/CodeSystem/GenericValues| Code | Display | Definition |
| none | Ingen immunoterapi | None - used to choose none of the available values |
https://kip.rkkp.dk/fhir/CodeSystem/ATC| Code | Display | Definition |
| L01FA01 | Rituximab | L01FA01 - rituximab |
| L01FA03 | Obinutuzumab | L01FA03 - obinutuzumab |
| L01FA02 | Ofatumumab | L01FA02 - ofatumumab |
| L04AA | MabCampath | L04AA - Selective immunosuppressants |
| L01FX05 | Brentuximab vedotin (Adcetris) | L01FX05 - brentuximab vedotin |
| L01FX14 | Polatuzumab incl evt. Rituximab | L01FX14 - polatuzumab vedotin |
| L01FF | PD(L)1 hæmmere | L01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
https://kip.rkkp.dk/fhir/CodeSystem/TreatmentUnspecified| Code | Display | Definition |
| glofitamab | Glofitamabel Epcoritamab Incl evt. Rituximab | Glofitamab |
{
"resourceType" : "ValueSet",
"id" : "Immunoterapi",
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet Immunoterapi</b></p><a name=\"Immunoterapi\"> </a><a name=\"hcImmunoterapi\"> </a><a name=\"Immunoterapi-en-US\"> </a><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href=\"CodeSystem-GenericValues.html\"><code>https://kip.rkkp.dk/fhir/CodeSystem/GenericValues</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-GenericValues.html#GenericValues-none\">none</a></td><td>Ingen immunoterapi</td><td>None - used to choose none of the available values</td></tr></table></li><li>Include these codes as defined in <a href=\"CodeSystem-ATC.html\"><code>https://kip.rkkp.dk/fhir/CodeSystem/ATC</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FA01\">L01FA01</a></td><td>Rituximab</td><td>L01FA01 - rituximab</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FA03\">L01FA03</a></td><td>Obinutuzumab</td><td>L01FA03 - obinutuzumab</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FA02\">L01FA02</a></td><td>Ofatumumab</td><td>L01FA02 - ofatumumab</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L04AA\">L04AA</a></td><td>MabCampath</td><td>L04AA - Selective immunosuppressants</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FX05\">L01FX05</a></td><td>Brentuximab vedotin (Adcetris)</td><td>L01FX05 - brentuximab vedotin</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FX14\">L01FX14</a></td><td>Polatuzumab incl evt. Rituximab</td><td>L01FX14 - polatuzumab vedotin</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FF\">L01FF</a></td><td>PD(L)1 hæmmere</td><td>L01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors</td></tr></table></li><li>Include these codes as defined in <a href=\"CodeSystem-TreatmentUnspecified.html\"><code>https://kip.rkkp.dk/fhir/CodeSystem/TreatmentUnspecified</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-TreatmentUnspecified.html#TreatmentUnspecified-glofitamab\">glofitamab</a></td><td>Glofitamabel Epcoritamab Incl evt. Rituximab</td><td>Glofitamab</td></tr></table></li></ul></div>"
},
"url" : "https://kip.rkkp.dk/fhir/ValueSet/Immunoterapi",
"version" : "2.11.0",
"name" : "Immunoterapi",
"title" : "Immunoterapi",
"status" : "active",
"experimental" : true,
"date" : "2022-07-18T00:00:00+02:00",
"publisher" : "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
"contact" : [
{
"name" : "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
"telecom" : [
{
"system" : "url",
"value" : "https://trifork.com"
},
{
"system" : "email",
"value" : "rbk@trifork.com"
}
]
}
],
"description" : "Immunoterapi",
"compose" : {
"include" : [
{
"system" : "https://kip.rkkp.dk/fhir/CodeSystem/GenericValues",
"concept" : [
{
"code" : "none",
"display" : "Ingen immunoterapi"
}
]
},
{
"system" : "https://kip.rkkp.dk/fhir/CodeSystem/ATC",
"concept" : [
{
"code" : "L01FA01",
"display" : "Rituximab"
},
{
"code" : "L01FA03",
"display" : "Obinutuzumab"
},
{
"code" : "L01FA02",
"display" : "Ofatumumab"
},
{
"code" : "L04AA",
"display" : "MabCampath"
},
{
"code" : "L01FX05",
"display" : "Brentuximab vedotin (Adcetris)"
},
{
"code" : "L01FX14",
"display" : "Polatuzumab incl evt. Rituximab"
},
{
"code" : "L01FF",
"display" : "PD(L)1 hæmmere"
}
]
},
{
"system" : "https://kip.rkkp.dk/fhir/CodeSystem/TreatmentUnspecified",
"concept" : [
{
"code" : "glofitamab",
"display" : "Glofitamabel Epcoritamab Incl evt. Rituximab"
}
]
}
]
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.